RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Catalys Pacific
C

Catalys Pacific portfolio

Catalys Pacific has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $255M.
Latest deal: Pathalys · Aug 20, 2024.
About this page

Its most recent investment on record is Pathalys's $105M Series B+ round in August 2024, alongside DaVita Venture Group, Marshall Wace, TCG Crossover and 4 others. That company is in Health and bio. It has co-invested with DaVita Venture Group, Samsara Biocapital and Marshall Wace, most often DaVita Venture Group (2 rounds).

What Catalys Pacific invests in

How Catalys Pacific invests

StageDealsCapital in rounds
Series B+ 1 50%$105M
Series A 1 50%$150M
YearDealsCapital in rounds
2023 1 50%$150M
2024 1 50%$105M

Catalys Pacific portfolio companies

CompanyRound with Catalys PacificTotal raisedLatest raise
PPathalys
Health and bio
Series B+ · $105M$255MAug 20, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Catalys Pacific. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Catalys Pacific, which is a subset of its real portfolio. API: /api/v1/investors/catalys-pacific (get a free API key). More: the most active VC firms and new venture capital funds.